Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.
暂无分享，去创建一个
A. Hagenbeek | J. Radford | K. Ardeshna | B. van der Holt | M. Ogura | W. Kim | S. Leppä | A. Davies | K. Kuliczkowski | S. Lisby | M. Matasar | X. Hong | A. McMillan | G. V. van Imhoff | M. Fennessy | Qiming M Liao | Jette Soenderskov Goerloev | M. D. C. Barrigón | Qiming Liao